10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Bone Cancer
1 article
Vincristine Infusion Time Does Not Affect Neuropathy in Pediatric Cancer
Study finds no difference in neuropathy between 1-hour and push injection of vincristine in children with cancer